Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Post by Chemguyon Oct 13, 2018 5:07pm

210 Views

Post# 28795347

APH Best positioned out of the top 5

Move onto Aphria and Rolfe takes a more sympathetic view, calling the company a “star unicorn” and praising its useful disclosure on strategies and operations. Rolphe says Aphria’s focus on cost management, cash-flow generation and accounting bodes well for its performance. He also thinks Aphria is “best positioned” to become a takeout candidate if industry consolidation gathers pace. Rolfe sets its price target at C$19. https://ca.proactiveinvestors.com/companies/news/207016/veritas-kicks-off-coverage-of-canada-s-cannabis-industry-with-sell-ratings-canopy-growth-aphria-aurora-cannabis-and-cronos-207016.html

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale